+44 (0)1509 263171
Please use this identifier to cite or link to this item:
|Title: ||Sensing interstitial glucose to nudge active lifestyles (SIGNAL): Feasibility of combining novel self-monitoring technologies for persuasive behaviour change|
|Authors: ||Whelan, Maxine E.|
Kingsnorth, Andrew P.
Orme, Mark W.
Sherar, Lauren B.
Esliger, Dale W.
|Issue Date: ||2017|
|Publisher: ||© The Authors. Published by BMJ Publishing Group|
|Citation: ||WHELAN, M.E. ...et al., 2017. Sensing interstitial glucose to nudge active lifestyles (SIGNAL): Feasibility of combining novel self-monitoring technologies for persuasive behaviour change. BMJ Open, 7:e018282.|
|Abstract: ||© Article author(s) 2017. Introduction Increasing physical activity (PA) reduces the risk of developing diabetes, highlighting the role of preventive medicine approaches. Changing lifestyle behaviours is difficult and is often predicated on the assumption that individuals are willing to change their lifestyles today to reduce the risk of developing disease years or even decades later. The self-monitoring technologies tested in this study will present PA feedback in real time, parallel with acute physiological data. Presenting the immediate health benefits of being more physically active may help enact change by observing the immediate consequences of that behaviour. The present study aims to assess user engagement with the self-monitoring technologies in individuals at moderate-to-high risk of developing type 2 diabetes. Methods and analysis 45 individuals with a moderate-to-high risk, aged ≥40 years old and using a compatible smartphone, will be invited to take part in a 7-week protocol. Following 1 week of baseline measurements, participants will be randomised into one of three groups: group 1 -glucose feedback followed by biobehavioural feedback (glucose plus PA); group 2 - PA feedback followed by biobehavioural feedback; group 3 - biobehavioural feedback. A PA monitor and a flash glucose monitor will be deployed during the intervention. Participants will wear both devices throughout the intervention but blinded to feedback depending on group allocation. The primary outcome is the level of participant engagement and will be assessed by device use and smartphone usage. Feasibility will be assessed by the practicality of the technology and screening for diabetes risk. Semistructured interviews will be conducted to explore participant experiences using the technologies. Trial registration number ISRCTN17545949. Registered on 15/05/2017.|
|Description: ||This is an Open Access Article. It is published by BMJ under the Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC). Full details of this licence are available at: http://creativecommons.org/licenses/by-nc/4.0/|
|Sponsor: ||This work will be funded in part by philanthropic support received from the late Dr the Honourable David Saul. This work has also been supported in part by the Higher Education Institution Challenge for Patient Supported Quality Improvement and Education in Health and Social Care (funded by the East Midlands
Academic Health Science Network) for the involvement of members of the public in research and by Loughborough University School of Sport, Exercise and Health Science for research facilitation funds.|
|Publisher Link: ||http://dx.doi.org/10.1136/bmjopen-2017-018282|
|Appears in Collections:||Published Articles (Sport, Exercise and Health Sciences)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.